Biomednewsbreaks Calidi Biotherapeutics Inc. (NYSE American: CLDI) And OS Therapies (NYSE American: OSTX) To Appear On Redchip's Bloomberg TV Show
Calidi Biotherapeutics (NYSE American: CLDI) and OS Therapies Inc. (NYSE American: OSTX) will be featured on RedChip's Small Stocks, Big MoneyTM sho ...
Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV
ORLANDO, FLORIDA / ACCESS Newswire / February 28, 2025 / RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and OS Therapies Inc. (NYSE American:OSTX) on the ...
Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and OS Therapies Inc. (NYSE American:OSTX) on the RedChip Small Stocks, Big Money™ show, a sponsored ...
Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on February 27
OS Therapies (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate biopharmaceutical company, is pleased to invite investors to a webinar ...
Future Market Insights6d
Upper Limb Prosthetics Market Poised to Reach USD 624.9 Million by 2033 at a 4.1% of CAGR
Upper Limb Prosthetics Market. The global upper limb prosthetics market is expected to grow from USD 398 million in 2023 to ...
OS Therapies Forms Subsidiary OS Drug Conjugates and Initiates Review of Strategic Options for its tunable ADC & Drug Conjugates Platforms
OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, announced the formation of subsidiary OS Drug ...
Frontiers8d
Identification and functional characterization of T-cell exhaustion-associated lncRNA AL031775.1 in osteosarcoma: a novel therapeutic target
Background: Osteosarcoma, an aggressive bone malignancy predominantly affecting children and adolescents, presents significant therapeutic challenges with a 5-year survival rate below 30% in ...
Pharmabiz8d
OS Therapies to receive US patent covering commercial manufacturing of OST-HER2
OS Therapies, Inc., a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, announced that it received a Notice of Allowance from the United ...
Eleven Warriors10d
Avery Henry, Ohio State Inspired Each Other in Buckeyes’ Run to National Championship
Avery Henry was grateful to be a part of Ohio State’s championship run as the former Buckeye whose career ended due to cancer ...
OS Therapies receives patent notice of allowance for OST-HER2
OS Therapies (OSTX) announced that it received a notice of allowance from the United States Patent & Trademark Office that a patent will be ...
Le Lézard11d
OS Therapies Receives Patent Notice of Allowance from U.S. Patent & Trademark Office Covering Commercial Manufacturing of OST-HER2
OS Therapies, Inc. , a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it received a Notice of Allowance from the ...
The Lancet12d
Children need space and support to talk about their pain
Pain has been a part of my life throughout my childhood. At the age of 12 years, I was diagnosed with metastatic osteosarcoma ...